Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinquan Lan
Institution:
Shenyang Center for Disease Control and Prevention
Observed institutions:
Hong Kong University of Science and Technology,
Peking University,
Shenyang Center for Disease Control and Prevention,
Peking University Shenzhen Hospital,
China Medical University
ORCID:
0000-0001-6621-777X
Observed ORCID:
0000-0001-6621-777X
OpenAlex ID:
A5049331487
Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey — Four PLADs, China, 2022
2023
·
Yuxiao Wang
, Lei Zhang
, et al.
·
China CDC Weekly
·
14
PDF
The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies
2023
·
Junjie Xu
, Xinquan Lan
, et al.
·
Frontiers in Public Health
·
11
PDF
Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: A Cross-Sectional Survey
2022
·
Junjie Xu
, Siyu Chen
, et al.
·
Vaccines
·
9
PDF
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
2023
·
Yuxiao Wang
, Ying Qiao
, et al.
·
Frontiers in Immunology
·
8
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
2024
·
Yuxiao Wang
, Xinquan Lan
, et al.
·
Journal of Medical Virology
·
6
Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China
2023
·
Xinquan Lan
, Bin Su
, et al.
·
Frontiers in Public Health
·
4
PDF
Low uptake of COVID-19 booster doses among elderly cancer patients in China: A multicentre cross-sectional study
2024
·
Ruiyu Chai
, Jianzhou Yang
, et al.
·
Journal of Global Health
·
3
PDF
Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022
2023
·
Fan Zhang
, Yaxin Zhu
, et al.
·
China CDC Weekly
·
3
PDF
Factors regarding blood donation willingness and preferences toward feedback between first-time donors and repeat donors in China: a cross-sectional survey
2026
·
Yuxiao Wang
, Lusheng Liu
, et al.
·
Frontiers in Medicine
·
2
PDF
Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China
2024
·
Liangyuan Zhang
, Jianzhou Yang
, et al.
·
Frontiers in Public Health
·
2
PDF
Efficacy of the third dose of COVID-19 vaccine: a systematic review and meta-analysis
2022
·
Junjie Xu
, Jiaye Liu
, et al.
PDF
Show more works
View as search
Works count:
11
Citation count:
62
H-index:
5
I10-index:
2
Year
Topic
Type